Jump to content

Dimepregnen

From Wikipedia, the free encyclopedia
Dimepregnen
Clinical data
ATC code
  • None
Identifiers
  • (3β,6α,16α)-3-Hydroxy-6,16-dimethylpregn-4-en-20-one
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC23H36O2
Molar mass344.539 g·mol−1
3D model (JSmol)
  • CC1CC2C3CC(C4=CC(CCC4(C3CCC2(C1C(=O)C)C)C)O)C
  • InChI=InChI=1S/C23H36O2/c1-13-10-17-18(22(4)8-6-16(25)12-19(13)22)7-9-23(5)20(17)11-14(2)21(23)15(3)24/h12-14,16-18,20-21,25H,6-11H2,1-5H3/t13-,14+,16-,17+,18-,20-,21+,22+,23-/m0/s1
  • Key:ATEJLEVEJWUXMA-XGYZZIOMSA-N

Dimepregnen (INN, BAN) (developmental code name ST-1411), or 6α,16α-dimethylpregn-4-en-3β-ol-20-one, is a pregnene steroid described as an antiestrogen that was synthesized in 1968 and was never marketed.[1][2] It is similar in structure to the progestins and progesterone derivatives melengestrol and anagestone.

See also

[edit]

References

[edit]
  1. ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 428–. ISBN 978-1-4757-2085-3.
  2. ^ "Report of the Special Committee on Organ Transplantation". British Medical Journal. 1 (5698): 750–1. March 1970. doi:10.1136/bmj.1.5698.750. PMC 1699868. PMID 5440553.